Shionogi Lifts Profit Outlook on HIV Royalties, Overseas Growth

Shionogi & Co. lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations.

The Japanese pharmaceutical company raised its full-year operating profit by 5.7% to ¥185 billion ($1.2 billion), beating analyst estimates.